Recombinant Antibodies Market

Recombinant Antibodies Market contains market size and forecasts of Recombinant Antibodies (rAbs) in global, including the following market information:

• Global Recombinant Antibodies (rAbs) Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Recombinant Antibodies (rAbs) Market Sales, 2017-2022, 2023-2028, (L)
• Global top five Recombinant Antibodies (rAbs) companies in 2021 (%)

The global Recombinant Antibodies (rAbs) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Rabbit Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Recombinant Antibodies (rAbs) include Abcam, Abeomics, Abnova Corporation, Absolute Antibody, Activity Signaling, AIVD Biotech, Bio X Cell, BioLegend and Bio-Rad, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Recombinant Antibodies (rAbs) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Recombinant Antibodies (rAbs) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (L)

Global Recombinant Antibodies (rAbs) Market Segment Percentages, by Type, 2021 (%)

• Rabbit
• Mouse
• Goat
• Others

Global Recombinant Antibodies (rAbs) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (L)

Global Recombinant Antibodies (rAbs) Market Segment Percentages, by Application, 2021 (%)

• Hospitals & Diagnostic Laboratories
• Pharmaceutical & Biotechnology
• Research Institutes
• Others

Global Recombinant Antibodies (rAbs) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (L)

Global Recombinant Antibodies (rAbs) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Recombinant Antibodies (rAbs) revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Recombinant Antibodies (rAbs) revenues share in global market, 2021 (%)
• Key companies Recombinant Antibodies (rAbs) sales in global market, 2017-2022 (Estimated), (L)
• Key companies Recombinant Antibodies (rAbs) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abcam
• Abeomics
• Abnova Corporation
• Absolute Antibody
• Activity Signaling
• AIVD Biotech
• Bio X Cell
• BioLegend
• Bio-Rad
• Bon Opus Biosciences
• Creative Biolabs
• Creative Diagnostics
• Enzo Life Sciences, Inc.
• GRP GmbH
• HUABIO
• Miltenyi Biotec
• NSJ Bioreagents
• PROGEN
• RevMab Biosciences USA, Inc.
• Signalway Antibody LLC